Charming Medical Limited Class A Ordinary Shares (MCTA) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
MCTA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MCTA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 67.2% | 22.3% | 19.3% |
| 2023 | 65.1% | 16.8% | 12.9% |
| 2022 | 42.3% | -14.8% | -8.6% |
Download Data
Export MCTA earnings history in CSV or JSON format
Free sign-in required to download data
Charming Medical Limited Class A Ordinary Shares (MCTA) Earnings Overview
As of May 8, 2026, Charming Medical Limited Class A Ordinary Shares (MCTA) reported trailing twelve-month net income of $1M, reflecting +54.2% year-over-year growth. The company earned $0.07 per diluted share over the past four quarters, with a net profit margin of 19.3%.
Looking at the long-term picture, MCTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $1M in fiscal 2024, representing a new all-time high.
Charming Medical Limited Class A Ordinary Shares maintains industry-leading profitability with a gross margin of 67.2%, operating margin of 22.3%, and net margin of 19.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including CANG (-$178M net income, 37.3% margin), CLOV (-$57M net income, -4.4% margin), ACMR ($94M net income, 10.4% margin), MCTA has room to improve margins relative to the peer group. Compare MCTA vs CANG →
MCTA Earnings vs Peers
Earnings metrics vs comparable public companies
MCTA Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1M | +54.2% | $1M | $0.07 | 19.3% | 22.3% |
| 2023 | $777,811 | +354.9% | $1M | $0.05 | 12.9% | 16.8% |
| 2022 | $-305,117 | - | $-521,336 | $-0.02 | -8.6% | -14.8% |
See MCTA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MCTA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MCTA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMCTA — Frequently Asked Questions
Quick answers to the most common questions about buying MCTA stock.
Is MCTA growing earnings?
MCTA EPS is $0.07, with earnings growth accelerating to +54.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $1M.
What are MCTA's profit margins?
Charming Medical Limited Class A Ordinary Shares net margin is +19.3%, with operating margin at +22.3%. Above-average margins indicate pricing power.
How consistent are MCTA's earnings?
MCTA earnings data spans 2022-2024. The accelerating earnings trend is +54.2% YoY. Historical data enables comparison across business cycles.